2.55 USD
↘ 0.11 (4.14%)AT CLOSE (03:59 PM EDT)
NewcelX Ltd. Ordinary Shares
NCELNASDAQ • USD
2.63
↗ 0.08 (3.18%)
POST MARKET (AS OF 04:04 PM EDT)
Post Market
AS OF 04:04 PM EDT
2.63
↗ 0.08 (3.18%)
Market: CLOSED
NewcelX Ltd. Ordinary Shares (NCEL) is currently trading at $2.69. Technical indicators currently signal "Strong Sell". This is driven by a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Oct 26, 2026.
Open?$2.49
High?$2.84
Low?$2.37
Prev. Close?$2.66
Volume?16.2K
Avg. Volume?N/A
VWAP?$2.61
Bid / Ask
Bid?$2.15 × 100
Ask?$3.13 × 100
Spread?$0.98
Midpoint?$2.64
Valuation & Ratios
Market Cap?15.4M
Shares Out?5.8M
Float?2.4M
Float %?45.2%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.
Themes
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.41%Low
Short Interest?9.8K
Days to Cover?2.1
Free Float2.4M
Avg Daily Volume4.7K
Settlement Date2026-10-15